ADVERTISEMENT

clinical trials

Breaking Down Barriers
Carina Storrs | Jul 1, 2015 | 7 min read
Finding and recruiting diverse populations for clinical studies
Celladon Shutters Its R&D
Kerry Grens | Jun 26, 2015 | 1 min read
Biotech firm likely to pull the plug after its gene therapy product fails.
Device Trials Go Unpublished
Kerry Grens | Jun 24, 2015 | 2 min read
Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.
Ebola Drug Trial Terminated
Amanda B. Keener | Jun 23, 2015 | 2 min read
Early analysis of TKM-Ebola-Guinea offers discouraging results, causing sponsors to end the Phase 2 trial.
NIH Halts Drug Production
Tracy Vence | Jun 8, 2015 | 1 min read
The National Institutes of Health’s Pharmaceutical Development Section temporarily suspends production following contamination issues.
Drug for Low Sex Drive in Women?
Jef Akst | Jun 8, 2015 | 2 min read
A federal advisory panel supports the US Food and Drug Administration’s approval of the first drug for female sexual dysfunction.
NCI Gets Personal
Bob Grant | Jun 2, 2015 | 2 min read
The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.
Clinical Matchmaker
Kate Yandell | Jun 1, 2015 | 8 min read
Enrolling the right patient population could be key to a successful clinical trial.
Viral Immunotherapy for Melanoma
Kerry Grens | May 28, 2015 | 2 min read
Phase 3 data from a clinical trial show a positive response to a melanoma treatment based on a modified herpesvirus.
Opinion: Public Data, Private Concerns
Viviane Callier | May 20, 2015 | 2 min read
Research participants aren’t always clear on open data policies when consenting to studies.
Clinical Epidemiology Pioneer Dies
Jenny Rood | May 18, 2015 | 1 min read
Evidence-based medicine advocate David Sackett has passed away at age 80.
Diagnosing Sepsis
Jef Akst | May 14, 2015 | 1 min read
An 11-gene set may help identify sepsis early, before it’s too late.
Restored Sight Fades After Gene Therapy
Jef Akst | May 5, 2015 | 2 min read
Participants of two gene-therapy trials who experienced partial restoration of sight following treatment are now losing their vision once again.
Duke Settles Negligence Suit
Tracy Vence | May 5, 2015 | 1 min read
Participants in controversial cancer trials have “resolved and settled all claims against” Duke University and oncologist Anil Potti, who previously admitted to fraud, lawyer says.
Hearts on Trial
Kerry Grens | May 1, 2015 | 10+ min read
As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.
Heart Strings
The Scientist | Apr 30, 2015 | 1 min read
An animated primer on the harvesting, growth, and administration of cardiac cells to heart attack patients
Eye Stem Cell Therapy Moves Ahead
Kate Yandell | Apr 30, 2015 | 4 min read
Researchers inject retinal support cells derived from human embryonic stem cells into the eyes of four men with macular degeneration, bolstering evidence of the experimental treatment’s safety.
FDA Calls for Data on ALS Drug
Jef Akst | Apr 21, 2015 | 2 min read
In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.
Study: Aspirin Reduces Cancer Risk
Bob Grant | Apr 20, 2015 | 2 min read
The largest and longest study of long-term, regular aspirin use finds that the drug may lead to a modestly reduced risk for some types of gastrointestinal cancers.
WHO: Share Trial Data
Tracy Vence | Apr 15, 2015 | 1 min read
The World Health Organization again calls upon researchers to register clinical trial details in freely accessible databases before initiation of the study.
ADVERTISEMENT